Logo image of XHLD

TEN HOLDINGS INC (XHLD) Stock Fundamental Analysis

NASDAQ:XHLD - Nasdaq - US8802451059 - Common Stock - Currency: USD

0.6749  -0.01 (-1.6%)

Fundamental Rating

0

XHLD gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 97 industry peers in the Media industry. Both the profitability and financial health of XHLD have multiple concerns. XHLD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

XHLD had negative earnings in the past year.
XHLD Yearly Net Income VS EBIT VS OCF VS FCFXHLD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 0 -2M -4M -6M

1.2 Ratios

Looking at the Return On Assets, with a value of -27.78%, XHLD is doing worse than 79.38% of the companies in the same industry.
Industry RankSector Rank
ROA -27.78%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
XHLD Yearly ROA, ROE, ROICXHLD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 -50 -100 -150 -200 -250

1.3 Margins

Looking at the Gross Margin, with a value of 85.08%, XHLD belongs to the top of the industry, outperforming 95.88% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for XHLD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.08%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XHLD Yearly Profit, Operating, Gross MarginsXHLD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 0 50 -50 -100 -150

More info and screens

0

2. Health

2.1 Basic Checks

XHLD does not have a ROIC to compare to the WACC, probably because it is not profitable.
XHLD has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, XHLD has a worse debt to assets ratio.
XHLD Yearly Shares OutstandingXHLD Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 5M 10M 15M 20M 25M
XHLD Yearly Total Debt VS Total AssetsXHLD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 1M 2M 3M 4M

2.2 Solvency

Based on the Altman-Z score of 0.33, we must say that XHLD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.33, XHLD is doing worse than 67.01% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.33
ROIC/WACCN/A
WACC8.77%
XHLD Yearly LT Debt VS Equity VS FCFXHLD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 1M -1M 2M

2.3 Liquidity

XHLD has a Current Ratio of 0.24. This is a bad value and indicates that XHLD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.24, XHLD is not doing good in the industry: 89.69% of the companies in the same industry are doing better.
A Quick Ratio of 0.24 indicates that XHLD may have some problems paying its short term obligations.
XHLD has a worse Quick ratio (0.24) than 89.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
XHLD Yearly Current Assets VS Current LiabilitesXHLD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

XHLD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 77.96%, which is quite impressive.
XHLD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.63%.
EPS 1Y (TTM)77.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-22.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
XHLD Yearly Revenue VS EstimatesXHLD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 1M 2M 3M 4M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

XHLD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
XHLD Price Earnings VS Forward Price EarningsXHLD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
XHLD Per share dataXHLD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

XHLD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TEN HOLDINGS INC

NASDAQ:XHLD (4/22/2025, 2:17:16 PM)

0.6749

-0.01 (-1.6%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change2.26%
Market Cap19.36M
AnalystsN/A
Price TargetN/A
Short Float %7.11%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.13
BVpS-0.03
TBVpS-0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -27.78%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.08%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z 0.33
F-ScoreN/A
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-22.63%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1481.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-33.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-419.28%
OCF growth 3YN/A
OCF growth 5YN/A